CID 16204651

5'-gagtgggtg-3'

Structural Information

Molecular Formula
C90H112N39O47P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=O)(OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)O)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)S)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O
InChI
InChI=1S/C90H112N39O47P9S9/c1-31-12-121(89(139)119-75(31)131)52-4-34(169-178(143,187)152-14-42-33(130)3-51(160-42)124-25-101-61-69(124)107-83(92)113-77(61)133)44(161-52)16-153-181(146,190)173-39-9-57(127-28-104-64-72(127)110-86(95)116-80(64)136)167-49(39)21-158-185(150,194)176-41-11-59(129-30-106-66-74(129)112-88(97)118-82(66)138)168-50(41)22-159-184(149,193)175-40-10-58(128-29-105-65-73(128)111-87(96)117-81(65)137)165-47(40)19-156-179(144,188)170-35-5-53(122-13-32(2)76(132)120-90(122)140)162-45(35)17-154-182(147,191)174-38-8-56(126-27-103-63-71(126)109-85(94)115-79(63)135)166-48(38)20-157-183(148,192)172-37-6-54(123-24-100-60-67(91)98-23-99-68(60)123)164-46(37)18-155-180(145,189)171-36-7-55(163-43(36)15-151-177(141,142)186)125-26-102-62-70(125)108-84(93)114-78(62)134/h12-13,23-30,33-59,130H,3-11,14-22H2,1-2H3,(H,143,187)(H,144,188)(H,145,189)(H,146,190)(H,147,191)(H,148,192)(H,149,193)(H,150,194)(H2,91,98,99)(H,119,131,139)(H,120,132,140)(H2,141,142,186)(H3,92,107,113,133)(H3,93,108,114,134)(H3,94,109,115,135)(H3,95,110,116,136)(H3,96,111,117,137)(H3,97,112,118,138)
InChIKey
OGSYWNGTCZRJNB-UHFFFAOYSA-N
Compound name
1-[5-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-(dihydroxyphosphinothioyloxymethyl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-sulfanylphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

3057.2698 Da
Monoisotopic Mass

-5.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3058.2771 294.9
[M+Na]+ 3080.2590 298.3
[M-H]- 3056.2625 295.1
[M+NH4]+ 3075.3036 296.2
[M+K]+ 3096.2330 296.6
[M+H-H2O]+ 3040.2671 295.4
[M+HCOO]- 3102.2680 296.4
[M+CH3COO]- 3116.2837 296.7
[M+Na-2H]- 3078.2445 298.8
[M]+ 3057.2693 298.3
[M]- 3057.2703 298.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.